ArticleScientific reports2026
Gastroenterological disease detection using transformer-based medical imaging for sustainable healthcare.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Capsule-enhanced hierarchical vision transformers for rare disease classification from medical images.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early detection of gastroenterological diseases significantly improves patient outcomes and reduces late-stage diagnostic burden, yet traditional CNN models show limitations in capturing complex patterns within medical imaging datasets, prompting investigation into transformer architectures like Vision Transformer (ViT). Application of the ViT technology in detecting gastroenterological diseases with the help of medical imaging has not been fully explored, despite the promising capabilities. In this paper, the effectiveness of the ViT-B16 structure for the identification of gastrointestinal abnormalities is considered using a combined dataset of Curated Colon Dataset and HyperKvasir Dataset (10,000 images across four classes), and compared with established methodologies. Our experimental results showed that ViT-B16 performed better when compared to alternative approaches; it achieved 99.5% classification accuracy compared to 99.1% by EfficientNetB5 and 97.1% by EfficientNetB2, with other supportive performance metrics including precision (99.4%), recall (99.4%), and F1-score (99.4%), AUC values ranged from 0.99 to 1.00 across all classes, reflecting very strong discriminatory power regarding disease classification tasks. These suggest that ViT-B16 has great potential for medical diagnosis applications, especially classification tasks in healthcare, where evidence-based decision-making and model interpretability are key considerations. The model also supports sustainable healthcare through computational efficiency and reduced diagnostic burden. However, there are several challenges that have not been addressed, including addressing ethical concerns about diagnostics, improving diagnostic accuracy for underrepresented disease classes, and validating the model across diverse clinical settings, which are essential directions for future research to continue developing gastroenterological disease-detecting techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.